Ignite Creation Date:
2025-12-24 @ 7:19 PM
Ignite Modification Date:
2025-12-31 @ 4:56 AM
Study NCT ID:
NCT01009203
Status:
TERMINATED
Last Update Posted:
2015-08-10
First Post:
2009-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-12
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-12
Completion Date Type:
ACTUAL
First Submit Date:
2009-11-05
First Submit QC Date:
None
Study First Post Date:
2009-11-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-15
Results First Submit QC Date:
None
Results First Post Date:
2015-08-10
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-07-14
Last Update Post Date:
2015-08-10
Last Update Post Date Type:
ESTIMATED